SBT-589 may be cardioprotective in FA
On March 19th, the pharmaceutical company Stealth BioTherapeutics presented data on their molecule called SBT-589 in preclinical models of Friedreich’s ataxia (FA) at the Wellcome Trust Conference on Mitochondrial Medicine-Therapeutic […]
SBT-589 may be cardioprotective in FA Read More »